GHK-Cu (50 mg Vial)

Complete dosage protocol and reconstitution guide for GHK-Cu (50 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
GHK-Cu (50 mg Vial)

CAT No:

CAS No:

Synonyms/Alias:GHK-Cu

M.F/Formula:

M.W/Mr.:

Purity:Specification by inquiry

Custom Peptide Support
  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Complete dosage protocol and reconstitution guide for GHK-Cu (50 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Quickstart

Reconstitute: Add 3.0 mL sterile water → 16.67 mg/mL concentration.

Typical range: 1.0–2.0 mg per injection (most common protocols use 5 days/week or 3×/week).

Easy measuring: At 16.67 mg/mL, 1 unit = 0.01 mL ≈ 167 mcg on a U‑100 insulin syringe.

Storage: Lyophilized: store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days.

Notes

Practical considerations for safe and consistent administration. Use new sterile insulin syringes for each injection; dispose in proper sharps containers. Rotate injection sites (abdomen at least 1 inch from navel, outer thighs, upper arms) to prevent irritation and lipodystrophy [12] [13] . Clean injection site with alcohol swab and allow to air-dry completely before injecting [14] . Inject slowly and steadily; withdraw needle at same angle as insertion. Document dose, date, and injection site to maintain consistency and track rotation.

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Source URL
https://peptide.cn.com/single-peptide-dosages/ghk-cu-50-mg-vial-dosage-protocol
Weeks 1–4
Dose per Injection: 1.0 mg (1000 mcg) | Units (per injection) (mL): 6 units (0.06 mL)
Weeks 5–8
Dose per Injection: 1.5 mg (1500 mcg) | Units (per injection) (mL): 9 units (0.09 mL)
Weeks 9–12+
Dose per Injection: 2.0 mg (2000 mcg) | Units (per injection) (mL): 12 units (0.12 mL)
Long-term Storage Conditions
Lyophilized: store at −20 °C (−4 °F) or below; reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F) and use within 30 days.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (GHK-Cu, 50 mg each): 5 days/week (1.0–2.0 mg/day):

8 weeks (~50 mg total) ≈ 1 vial

12 weeks (~90 mg total) ≈ 2 vials

16 weeks (~130 mg total) ≈ 3 vials

3×/week (2 mg each):

8 weeks (~48 mg) ≈ 1 vial

12 weeks (~72 mg) ≈ 2 vials

16 weeks (~96 mg) ≈ 2 vials

Insulin Syringes (U‑100, 29–31 gauge): 5 days/week:

Per week: 5 syringes

8 weeks: 40 syringes

12 weeks: 60 syringes

16 weeks: 80 syringes

3×/week:

Per week: 3 syringes

8 weeks: 24 syringes

12 weeks: 36 syringes

16 weeks: 48 syringes

Sterile or Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 1 vial protocols: 3 mL → 1 × 10 mL bottle

2 vial protocols: 6 mL → 1 × 10 mL bottle

Product Gallery
Quick Inquiry
Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsApp Mia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China